Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

With MISSON Act, Veterans Get More Convenient but Potentially Worse CV Care

News Daily News

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Yael L. Maxwell

August 08, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

Yael L. Maxwell

July 11, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Todd Neale

February 11, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

Advertisement

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Cannabis Use Again Tied to Increased CVD Risk in Young People

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

ACC/AHA Release New Comprehensive ACS Guidelines

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

TCTMD’s Top 10 Most Popular Stories for January 2025

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content